Baolait Technology Co., Ltd.

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Legal Opinion from Guangdong Jingcheng Yueheng Law Firm Regarding the 2025 Annual Shareholders' Meeting of Guangdong Baolait Medical Technology Co., Ltd.

Announcement of Resolutions of the Ninth Meeting of the Ninth Board of Directors

Announcement on Not Lowering the Conversion Price of Baolai Convertible Bonds

Announcement on the Anticipated Trigger of Downward Adjustment Conditions for Convertible Bond Conversion Price

Reminder Announcement on the Disclosure of the 2025 Annual Report

Announcement on the Confirmation of Director and Senior Management Compensation for 2025 and the Compensation Plan for 2026

2025 Annual Board Work Report

2025 Annual Financial Settlement Report

Independent Director 2025 Annual Work Report (Xue Jundong)

Independent Director 2025 Annual Work Report (Chen Jian)

Independent Director 2025 Annual Work Report (Ran Maoliang)

Independent Director 2025 Annual Work Report (Yang Zhenxin)

Announcement on Holding the 2025 Annual Performance Online Presentation

2025 Internal Control Audit Report

2025 Internal Control Evaluation Report

Insider Information Insider Management System (Revised April 2026)

Internal Control Deficiency Identification Standards (Revised April 2026)

Investor Relations Management System (Revised April 2026)

Work Rules of the Compensation and Assessment Committee (Revised April 2026)

Information Disclosure System (Revised April 2026)

Work Rules of the Strategic Committee (Revised April 2026)

Director and Senior Management Compensation Management System

Accounting Firm Selection System (Revised April 2026)

External Information Submission and Usage Management System (Revised April 2026)

Management System for Holding Subsidiaries (Revised April 2026)

Announcement on the Provision for Asset Impairment for 2025

Announcement on the Expected Daily Related Transactions for 2026

Announcement on the Company's and Subsidiaries' Application for Comprehensive Credit Limits from Banks and Other Financial Institutions and Providing Guarantees for Subsidiaries

Notice of the 2025 Annual Shareholders' Meeting

Announcement of the Resolutions of the Eighth Meeting of the Ninth Board of Directors

Special Explanation on the Proposed Non-Distribution of Profits for 2025

Q1 2026 Report

Special Report on the Storage and Use of Fund Raised in 2025

Verification Report on the Storage and Actual Use of Fund Raised by Guangdong Baolait Medical Technology Co., Ltd. in 2025

Verification Opinion of Caitong Securities Co., Ltd. on the Storage and Use of Fund Raised by Guangdong Baolait Medical Technology Co., Ltd. in 2025

Special Verification Report on the Revenue Deduction Situation of Guangdong Baolait Medical Technology Co., Ltd.

Report of the Board Audit Committee on the Evaluation of the Accounting Firm's Performance in 2025 and the Fulfillment of Supervision Responsibilities

Special Explanation on the Company's Non-Operating Fund Occupation and Other Related Fund Transactions

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for 2025

Special Opinion from the Board on the Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary

Announcement on the Conversion of Convertible Corporate Bonds in the First Quarter of 2026

Caitong Securities Co., Ltd. 2026 First Interim Trustee Management Report on Guangdong Biolight Meditech Co., Ltd.'s Public Issuance of Convertible Corporate Bonds to Unspecified Investors in 2025

Guangdong Jingcheng Yueheng Law Firm's Legal Opinion on Guangdong Biolight Meditech Co., Ltd.'s First Extraordinary General Meeting of Shareholders in 2026

Announcement of Resolutions of the First Extraordinary General Meeting of Shareholders in 2026

Announcement of Resolutions of the Seventh Meeting of the Ninth Board of Directors

Announcement on the Downward Revision of the Conversion Price of Convertible Corporate Bonds

Announcement on the Release of Pledge of Partial Shares by the Actual Controller

Announcement on the Board of Directors' Proposal to Amend Downwards the Conversion Price of Baolai Convertible Bonds

Notice of Convening the First Extraordinary General Meeting of Shareholders in 2026

Announcement of Resolutions of the Sixth Meeting of the Ninth Board of Directors